RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vitaspring Biomedical Co. Stock

Vitaspring Biomedical Co. Equity 2024

Vitaspring Biomedical Co. Equity

1.58 M USD

Ticker

VSBC

ISIN

US92851B1026

In 2024, Vitaspring Biomedical Co.'s equity was 1.58 M USD, a 1,480% increase from the 100,000 USD equity in the previous year.

Vitaspring Biomedical Co. Aktienanalyse

What does Vitaspring Biomedical Co. do?

Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Vitaspring Biomedical Co.'s Equity

Vitaspring Biomedical Co.'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vitaspring Biomedical Co.'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vitaspring Biomedical Co.'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vitaspring Biomedical Co.'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vitaspring Biomedical Co.’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vitaspring Biomedical Co. stock

What is the equity of Vitaspring Biomedical Co. this year?

Vitaspring Biomedical Co. has equity of 1.58 M USD this year.

What was the equity of Vitaspring Biomedical Co. compared to the previous year?

The equity of Vitaspring Biomedical Co. has increased/decreased by 1,480% increased compared to the previous year.

What impact does a high equity have on investors of Vitaspring Biomedical Co.?

A high equity is advantageous for investors of Vitaspring Biomedical Co. as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Vitaspring Biomedical Co.?

A low equity can be a risk for investors of Vitaspring Biomedical Co., as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Vitaspring Biomedical Co. affect the company?

An increase in equity of Vitaspring Biomedical Co. can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Vitaspring Biomedical Co. affect the company?

A reduction in equity of Vitaspring Biomedical Co. can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Vitaspring Biomedical Co.?

Some factors that can affect the equity of Vitaspring Biomedical Co. include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Vitaspring Biomedical Co. so important for investors?

The equity of Vitaspring Biomedical Co. is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Vitaspring Biomedical Co. take to change the equity?

To change equity, Vitaspring Biomedical Co. can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Vitaspring Biomedical Co. pay?

Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of Vitaspring Biomedical Co.?

The current dividend yield of Vitaspring Biomedical Co. is .

When does Vitaspring Biomedical Co. pay dividends?

Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vitaspring Biomedical Co.?

Vitaspring Biomedical Co. paid dividends every year for the past 0 years.

What is the dividend of Vitaspring Biomedical Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vitaspring Biomedical Co. located?

Vitaspring Biomedical Co. is assigned to the '-' sector.

Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vitaspring Biomedical Co. from 12/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.

When did Vitaspring Biomedical Co. pay the last dividend?

The last dividend was paid out on 12/24/2024.

What was the dividend of Vitaspring Biomedical Co. in the year 2023?

In the year 2023, Vitaspring Biomedical Co. distributed 0 USD as dividends.

In which currency does Vitaspring Biomedical Co. pay out the dividend?

The dividends of Vitaspring Biomedical Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vitaspring Biomedical Co.

Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.